This section of the Karyopharm Therapeutics InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing.
Please note: All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes. Karyopharm Therapeutics assumes no responsibility for the accuracy of this data and provides it for informational purposes only.
|Average Volume (10 days)||1.1M|
|Qtrly Dividend (Ann. Yield)||-- (--)|
|Current Mean Recommendation||Buy|
Recent Insider Transactions
Sep 12, 2023
Aug 31, 2023
Aug 7, 2023
EVP, Chief Development Officer
Jul 28, 2023
Chief Commercial Officer
Jun 8, 2023